PROM2 decreases cisplatin sensitivity in non-small cell lung cancer and is regulated by CTCF. Radiol Oncol [Internet]. 2023 Sep. 11 [cited 2026 Sep. 24];57(3):325-36. Available from: https://radioloncol.com/index.php/ro/article/view/4013